No Data
The "DeepSeek Moment" of medicine, has China’s Innovative Drugs also reached it?
Over the past four years, China's share of Global large-scale pharmaceutical Trade has surged from 5% to 30%. From research and development innovation to international mergers and acquisitions, Chinese Innovative Drugs companies are reshaping the Global pharmaceutical innovation landscape.
Fudan Zhangjiang 2024 Annual Results Forecast Announcement
Fudan-Zhangjiang Bio-Pharma Expects Up to 68% Lower Net Profit in 2024
Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Sees Unaudited Net Profit Attributable RMB35 Mln to RMB52 Mln for Year
FUDANZHANGJIANG: INSIDE INFORMATION / PROFIT WARNING
Announcement Highlights | Wanwu Cloud acquires 100% equity of Zhongzhou Property; UBTECH executives commit not to reduce their Shareholding within 12 months.
C&D INTL GROUP: The cumulative contract sales amount for 2024 is about 103.36 billion yuan, a year-on-year decrease of about 25.1%; SHIMAO SERVICES plans to acquire 33% of Shenzhen Shilu Yuan Environmental for 83.159 million yuan for full ownership.
